Celldex Therapeutics, Inc. – ‘10-Q’ for 6/30/22 – ‘ZIP’

On:  Monday, 8/8/22, at 4:06pm ET   ·   For:  6/30/22   ·   Accession #:  1104659-22-87222   ·   File #:  0-15006

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    735K 
 2: EX-10.3     Material Contract                                   HTML     29K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     22K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     22K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
11: R1          Document and Entity Information                     HTML     73K 
12: R2          Condensed Consolidated Balance Sheets               HTML    113K 
13: R3          Condensed Consolidated Balance Sheets               HTML     35K 
                (Parenthetical)                                                  
14: R4          Condensed Consolidated Statements of Operations     HTML     86K 
                and Comprehensive Loss                                           
15: R5          Condensed Consolidated Statements of Cash Flow      HTML     80K 
16: R6          Basis of Presentation                               HTML     25K 
17: R7          Significant Accounting Policies                     HTML     21K 
18: R8          Fair Value Measurements                             HTML     96K 
19: R9          Marketable Securities                               HTML    110K 
20: R10         Intangible Assets                                   HTML     20K 
21: R11         Other Long-Term Liabilities                         HTML     36K 
22: R12         Stockholders' Equity                                HTML    153K 
23: R13         Stock-Based Compensation                            HTML     81K 
24: R14         Accumulated Other Comprehensive Income              HTML     40K 
25: R15         Revenue                                             HTML     23K 
26: R16         Income Taxes                                        HTML     22K 
27: R17         Net Loss Per Share                                  HTML     27K 
28: R18         Kolltan Acquisition                                 HTML     28K 
29: R19         Significant Accounting Policies (Policies)          HTML     20K 
30: R20         Fair Value Measurements (Tables)                    HTML     95K 
31: R21         Marketable Securities (Tables)                      HTML    108K 
32: R22         Other Long-Term Liabilities (Tables)                HTML     35K 
33: R23         Stockholders' Equity (Tables)                       HTML    148K 
34: R24         Stock-Based Compensation (Tables)                   HTML     84K 
35: R25         Accumulated Other Comprehensive Income (Tables)     HTML     39K 
36: R26         Net Loss Per Share (Tables)                         HTML     26K 
37: R27         Basis of Presentation (Details)                     HTML     30K 
38: R28         Fair Value Measurements (Details)                   HTML     45K 
39: R29         Fair Value Measurements - Contingent Consideration  HTML     26K 
                Liabilities (Details)                                            
40: R30         Fair Value Measurements - Additional information    HTML     29K 
                (Details)                                                        
41: R31         Marketable Securities (Details)                     HTML     58K 
42: R32         Marketable Securities - Additional Information      HTML     21K 
                (Details)                                                        
43: R33         Intangible Assets (Details)                         HTML     19K 
44: R34         Other Long-Term Liabilities (Details)               HTML     32K 
45: R35         Other Long-Term Liabilities- New Jersey tax         HTML     26K 
                benefits (Details)                                               
46: R36         Stockholders' Equity (Details)                      HTML     60K 
47: R37         Stock-Based Compensation - Stock Option Activity    HTML     64K 
                (Details)                                                        
48: R38         Stock-Based Compensation - Employee Stock Option    HTML     29K 
                and Incentive Plan Activity Additional Information               
                (Details)                                                        
49: R39         Stock-Based Compensation - Expenses (Details)       HTML     24K 
50: R40         Stock-Based Compensation - Valuation (Details)      HTML     32K 
51: R41         Accumulated Other Comprehensive Income (Details)    HTML     38K 
52: R42         Revenue (Details)                                   HTML     38K 
53: R43         Income Taxes (Details)                              HTML     19K 
54: R44         Net Loss Per Share (Details)                        HTML     22K 
55: R45         Kolltan Acquisition (Details)                       HTML     39K 
58: XML         IDEA XML File -- Filing Summary                      XML    103K 
56: XML         XBRL Instance -- cldx-20220630x10q_htm               XML   1.45M 
57: EXCEL       IDEA Workbook of Financial Reports                  XLSX     61K 
 7: EX-101.CAL  XBRL Calculations -- cldx-20220630_cal               XML    114K 
 8: EX-101.DEF  XBRL Definitions -- cldx-20220630_def                XML    327K 
 9: EX-101.LAB  XBRL Labels -- cldx-20220630_lab                     XML    756K 
10: EX-101.PRE  XBRL Presentations -- cldx-20220630_pre              XML    529K 
 6: EX-101.SCH  XBRL Schema -- cldx-20220630                         XSD     94K 
59: JSON        XBRL Instance as JSON Data -- MetaLinks              248±   365K 
60: ZIP         XBRL Zipped Folder -- 0001104659-22-087222-xbrl      Zip    161K 

‘ZIP’   —   XBRL Zipped Folder — 0001104659-22-087222-xbrl

This is an XBRL Zipped Folder.

	Download this zipped .zip folder
Files:	cldx-20220630.xsd cldx-20220630_cal.xml cldx-20220630_def.xml cldx-20220630_lab.xml cldx-20220630_pre.xml cldx-20220630x10q.htm cldx-20220630xex10d3.htm cldx-20220630xex31d1.htm cldx-20220630xex31d2.htm cldx-20220630xex32d1.htm

2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/26/24  Celldex Therapeutics, Inc.        10-K       12/31/23   87:8.5M                                   Toppan Merrill/FA2
 2/28/23  Celldex Therapeutics, Inc.        10-K       12/31/22   85:8.1M                                   Toppan Merrill/FA

2 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/18/22  Celldex Therapeutics, Inc.        8-K:1,9     7/15/22   11:257K                                   Toppan Merrill/FA
 6/23/22  Celldex Therapeutics, Inc.        8-K:1,2,9   6/20/22   11:225K                                   Toppan Merrill/FA